Cardiff Oncology, Inc.
Cardiff Oncology, Inc. (CRDF) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 47 transactions totaling $3.3M, demonstrating a bullish sentiment with $2.0M in net insider flow. The most recent transaction on Jul 30, 2025 involved a purchase of 15,000 shares valued at $36.8K.
CRDF Insider Activity Summary
Who Is Buying CRDF Stock?
No significant insider buying has been recorded for CRDF in the recent period.
Who Is Selling CRDF Stock?
No significant insider selling has been recorded for CRDF in the recent period.
Is Cardiff Oncology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CRDF is bullish with an Insider Alignment Score of 80/100 and a net flow of $2.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CRDF Frequently Asked Questions
Understanding CRDF Insider Activity
Insider trading at Cardiff Oncology, Inc. (CRDF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading CRDF stock, having executed 47 transactions in the past 90 days. The most active insider is Gary W. Pace (Executive), who has made 15 transactions totaling $2.0M.
Related Tools
Track Cardiff Oncology, Inc. Insider Activity
Get notified when executives and directors at CRDF file new Form 4 transactions